Ozempic 0.25 mg (Semaglutide) Pre-Filled Injection Pen – Once-Weekly GLP-1 Prescription Medication

Take an important step toward better blood sugar management with Ozempic® 0.25 mg (Semaglutide) Pre-Filled Injection Pen, an innovative once-weekly prescription medication developed by Novo Nordisk. Designed for adults living with type 2 diabetes, Ozempic helps improve glycemic control when combined with a healthy diet and regular physical activity. Its easy-to-use, pre-filled injection pen offers a convenient dosing schedule, making long-term treatment more manageable for eligible patients.

Ozempic contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist that works by helping the body release insulin when blood sugar levels are elevated, reducing glucose production by the liver, and slowing gastric emptying. These combined effects help improve blood glucose control and may also promote feelings of fullness, which can contribute to weight reduction in some patients under medical supervision.

The 0.25 mg dose is typically used as the initial starting dose to help the body adjust to treatment before progressing to higher maintenance doses as directed by a healthcare provider. Ozempic is administered once weekly, with or without meals, using a simple subcutaneous injection in the abdomen, thigh, or upper arm.

Manufactured by Novo Nordisk, Ozempic has become one of the most widely prescribed GLP-1 medications for adults with type 2 diabetes. In addition to improving blood sugar control, it has also been shown to reduce the risk of major cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease when used as prescribed.

Each package contains one multi-dose pre-filled injection pen and four disposable needles, providing up to four weekly doses at the 0.25 mg strength. The compact pen is designed for accurate dosing and ease of use, making it suitable for patients beginning semaglutide therapy.

Whether you are starting GLP-1 treatment or following your healthcare provider’s prescribed diabetes management plan, Ozempic® 0.25 mg offers a clinically proven, convenient once-weekly solution to support better glycemic control and overall treatment adherence.

Key Features

• Contains Semaglutide 0.25 mg
• Genuine Ozempic® by Novo Nordisk
• Once-weekly subcutaneous injection
• Easy-to-use multi-dose pre-filled injection pen
• Helps improve blood sugar control in adults with type 2 diabetes
• May support weight reduction when prescribed appropriately
• May reduce the risk of major cardiovascular events in eligible patients
• Four weekly doses per pen
• Includes four sterile disposable needles
• Suitable for use alongside diet and exercise
• Prescription-only medication

What’s Included

• 1 × Ozempic® 0.25 mg Multi-Dose Pre-Filled Pen
• 4 × Disposable Pen Needles
• Manufacturer’s Patient Information Leaflet (where supplied)

Active Ingredient

Semaglutide

Strength

0.25 mg

Dosage Form

Multi-Dose Pre-Filled Injection Pen

Administration

Inject once weekly under the skin (subcutaneously) into the abdomen, thigh, or upper arm, exactly as directed by your healthcare provider.

Storage Instructions

• Store unopened pens refrigerated between 2°C and 8°C (36°F–46°F).
• Do not freeze or use if frozen.
• Protect from direct heat and sunlight.
• Keep out of reach of children.
• Follow the storage instructions provided in the manufacturer’s leaflet after first use.

Important Safety Information

Ozempic® is a prescription-only medicine intended for adults with type 2 diabetes. It is not indicated for type 1 diabetes or for the treatment of diabetic ketoacidosis. Use only under the supervision of a qualified healthcare professional.

Do not use Ozempic if you have experienced an allergic reaction to semaglutide or any of its ingredients. Discuss your complete medical history with your healthcare provider before beginning treatment, especially if you have a history of pancreatitis, severe gastrointestinal disease, kidney problems, or are pregnant or breastfeeding.

Always read the patient information leaflet before use and follow your healthcare provider’s instructions carefully.

Why Choose Ozempic® 0.25 mg?

Ozempic combines advanced GLP-1 receptor agonist technology with the convenience of once-weekly dosing, helping eligible adults manage type 2 diabetes with fewer injections compared with many daily therapies. Manufactured to high pharmaceutical standards by Novo Nordisk, Ozempic offers an easy-to-use pen system, clinically established efficacy, and a treatment option trusted by healthcare professionals worldwide.

Intended Use

Ozempic is prescribed to:

• Improve blood sugar control in adults with Type 2 Diabetes
• Reduce the risk of major cardiovascular events in eligible adults with Type 2 Diabetes and established cardiovascular disease
• Support weight reduction when prescribed by a healthcare professional (subject to local approval and prescribing practices)

More specifically:

• Drug class: GLP-1 receptor agonist
• Active ingredient: Semaglutide
• Type: Synthetic peptide (an analog of the naturally occurring hormone GLP-1)
• Administration: Subcutaneous injection (once weekly)

Semaglutide is made up of a chain of amino acids, making it a peptide. It is engineered to mimic the body’s natural glucagon-like peptide-1 (GLP-1) hormone, but with modifications that allow it to remain active in the body for about a week, enabling once-weekly dosing.

What does it do?

Semaglutide works by:

• Stimulating insulin release when blood sugar is elevated.
• Reducing glucagon secretion, which lowers glucose production by the liver.
• Slowing stomach emptying, helping control blood sugar after meals.
• Increasing feelings of fullness, which can reduce appetite and calorie intake.

Is Ozempic a peptide or a weight-loss drug?

It is both, depending on the context:

• Chemically: It is a synthetic peptide.
• Therapeutically: It is primarily a prescription medication for type 2 diabetes. It may also contribute to weight loss, but Ozempic itself is approved for diabetes treatment, while higher-dose semaglutide is marketed under a different brand in some countries specifically for chronic weight management.

Frequently Asked Questions (FAQs)

1. What is Ozempic® 0.25 mg used for?

Ozempic® 0.25 mg (semaglutide) is a prescription medication used to improve blood sugar control in adults with type 2 diabetes when used alongside a healthy diet and regular exercise. In some patients, it may also reduce the risk of major cardiovascular events, depending on their medical history and healthcare provider’s recommendations.

---

2. Is Ozempic® a peptide?

Yes. Ozempic contains semaglutide, a synthetic GLP-1 peptide (glucagon-like peptide-1 receptor agonist) designed to mimic the body’s natural GLP-1 hormone, helping regulate blood sugar and appetite.

---

3. How often is Ozempic® 0.25 mg injected?

Ozempic® is administered once weekly by subcutaneous injection. It should be used on the same day each week, with or without food, as directed by your healthcare provider.

---

4. Is the 0.25 mg dose a maintenance dose?

No. The 0.25 mg dose is generally the starting dose, intended to help your body adjust to treatment. Your healthcare provider may increase your dose after the initial treatment period based on your response and treatment goals.

---

5. Does Ozempic® help with weight loss?

Some people taking Ozempic® may experience weight loss due to reduced appetite and slower stomach emptying. However, Ozempic is primarily prescribed for type 2 diabetes, and it should only be used for approved indications or as directed by a licensed healthcare provider.

---